Alps Advisors Inc 89bio, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in 89bio, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 81,349 shares of ETNB stock, worth $677,637. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,349

Previous 76,750 5.99%

Holding current value

$677,637

Previous $614,000 2.12%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.36 - $9.66 $33,848 - $44,426	4,599 Added 5.99%	81,349 $601,000
Q2 2024 Aug 13, 2024	BUY	$7.31 - $10.9 $78,969 - $117,752	10,803 Added 16.38%	76,750 $614,000
Q1 2024 May 14, 2024	BUY	$8.13 - $13.77 $109,681 - $185,771	13,491 Added 25.72%	65,947 $767,000
Q4 2023 Feb 14, 2024	SELL	$6.66 - $16.03 $21,411 - $51,536	-3,215 Reduced 5.77%	52,456 $585,000
Q3 2023 Nov 14, 2023	BUY	$15.06 - $19.41 $31,761 - $40,935	2,109 Added 3.94%	55,671 $859,000
Q2 2023 Aug 14, 2023	BUY	$14.15 - $22.03 $286,537 - $446,107	20,250 Added 60.79%	53,562 $1.01 Million
Q1 2023 May 10, 2023	BUY	$10.48 - $16.94 $18,119 - $29,289	1,729 Added 5.47%	33,312 $507,000
Q4 2022 Feb 14, 2023	BUY	$5.52 - $12.73 $174,338 - $402,051	31,583 New	31,583 $402,000
Q2 2022 Aug 11, 2022	SELL	$2.09 - $4.02 $43,944 - $84,524	-21,026 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.45 - $14.99 $8,428 - $36,620	-2,443 Reduced 10.41%	21,026 $79,000
Q4 2021 Feb 09, 2022	SELL	$11.15 - $19.66 $12,755 - $22,491	-1,144 Reduced 4.65%	23,469 $307,000
Q3 2021 Nov 15, 2021	SELL	$14.91 - $21.31 $26,957 - $38,528	-1,808 Reduced 6.84%	24,613 $482,000
Q2 2021 Aug 11, 2021	SELL	$17.42 - $28.0 $166,151 - $267,064	-9,538 Reduced 26.52%	26,421 $494,000
Q1 2021 May 07, 2021	BUY	$20.22 - $26.73 $566 - $748	28 Added 0.08%	35,959 $852,000
Q4 2020 Feb 03, 2021	BUY	$23.16 - $28.08 $832,161 - $1.01 Million	35,931 New	35,931 $876,000

Others Institutions Holding ETNB

# of Institutions

158

Shares Held

108M

Call Options Held

73.6K

Put Options Held

1.19M

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $387M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc 89bio, Inc. Transaction History